1 Min Read
June 15 (Reuters) - Rasrx :
* Rasrx receives orphan drug designation from FDA
* U.S. FDA has granted an orphan drug designation for its compound RASRx1902 for treatment of duchenne muscular dystrophy Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.